Know Before the Cliff: How AI and Patent Analytics Let You See Generic Competition Coming
The cliff is coming. The question is whether you can see it.
In pharma, “the cliff” isn’t a metaphor—it’s a calendar. It’s the moment exclusivity ends, the moment generic competition becomes legally possible, and the moment pricing power can evaporate …
